360° Coverage : What Are Bidis And Why Is The FDA Regulating Tobacco Products?

2 Updates

What Are Bidis And Why Is The FDA Regulating Tobacco Products?

Feb 25 2014, 8:53am CST | by

Last week, FDA’s Center for Tobacco Products issued their first regulatory action since being established by an act of Congress in 2009. An Indian company, Jash International, was instructed...

Filed under: news


29 weeks ago

What Are Bidis And Why Is The FDA Regulating Tobacco Products?

Feb 25 2014, 8:53am CST | by

Last week, FDA’s Center for Tobacco Products issued their first regulatory action since being established by an act of Congress in 2009. An Indian company, Jash International, was instructed to cease U.S. import, distribution, and sales of four brands of bidis, a tobacco smoking product that’s rolled in the leaves of the tendu plant, instead of paper, then tied with string. The specific bidi products are sold as Sutra Bidis Red, Sutra Bidis Menthol, Sutra Bidis Red Cone, and Sutra Bidis Menthol Cone.

An article in The Times of India suggests that Jash International is not a particularly well-known company in its home country, so this first FDA warning might be serving as a shakedown cruise for exercising their regulatory might. The company was cited for not registering their products with the FDA, an application that would likely have been turned down anyway since bidis do not meet the standards of having a “predicate product” sold in the U.S. as of February 15, 2007. What that means is that tobacco products sold as of that date serve as the standard to which new tobacco products are compared with for “substantial equivalence.”

The Act has been criticized in some circles as protecting the large tobacco manufacturers whose previously marketed products serve as such standards.

The FDA’s CTP order results from the authority provided under the Family Smoking Prevention and Tobacco Control Act of 2009, “to regulate the manufacture, distribution, and marketing of tobacco products to protect public health.”

Several local folks I spoke with were not aware that the FDA had regulatory authority of tobacco products, certainly not since 2009. A typical response is “Why would FDA regulate a potentially lethal product?” Indeed, use of tobacco products results in over 440,000 death per year in the U.S. alone.

In the briefest possible terms, the FDA Center for Tobacco Products takes a harm reduction approach to tobacco use in the U.S. The Act established the CTP’s mission as three-fold: 1) to prevent Americans—especially youth—from starting to use tobacco, 2) encourage current users to quit, and 3) decrease the harms of tobacco product use.

To accomplish this mission, the CTP has the authority to require tobacco companies to register their products with the FDA, disclose the content of the product, including nicotine and tar content, limit how tobacco is distributed and sold, and review new tobacco products before they are marketed. Of course, this is one activity where the FDA does not require proof of efficacy or safety. Rather, the products are being regulated to minimize their health risks for Americans who choose to continue smoking.

A major effort is directed at minimizing tobacco sales and promotion to minors, including a ban on all candy and fruit-type flavorings other than menthol. The special dispensation of menthol was a sticking point during legislative deliberations since its inclusion in cigarettes appeals disproportionate to minority groups and causes smoke to be inhaled more deeply into the lungs.

Interestingly, the Act only applies to manufactured or hand-rolled cigarettes, the tobacco used therein, and smokeless tobacco. Cigars do not fall under the Act, nor do the increasingly popular nicotine delivery devices, e-cigarettes.

However, a “Unified Agenda” statement from the FDA and the U.S. Department of Health and Human Services was published in Fall 2013 to give the CTP authority to regulate, “hookah, electronic cigarettes, cigars, pipe tobacco, other novel tobacco products, and future tobacco products.”

The Act represents the compromise from a long battle for complete prohibition of tobacco products that began with the FDA commissioner tenure of Dr. David Kessler from 1990 to 1997.

Kessler documents the history of tobacco regulation in a highly-readable and sometimes suspenseful 2002 book, “A Question of Intent: A Great American Battle With A Deadly Industry.” A Johns Hopkins-trained pediatrician with a University of Chicago law degree, Kessler was not new to politics. He had served as an advisor to Senator Orrin Hatch (R-Utah), who described him in 1991 as, “one of the brightest, most decent men I know.” Kessler had also taught food and drug law at Columbia.

Kessler is well-known to Forbes Pharma & Healthcare readers since his one of his major contributions was to accelerate the pace at which the FDA reviewed and approved pharmaceuticals. Among his accomplishment was to enable the agency to use surrogate endpoints of efficacy as the basis for approval of drugs to treat serious, life-threatening diseases. For example, an increase in CD4+ T lymphocytes was used as a surrogate marker of efficacy of HIV reverse transcriptase inhibitors instead of, say, five-year patient survival.

But Kessler also felt that if nicotine was a drug – which it is in pharmacological terms – and that the FDA regulates all chemicals that come in contact with our bodies, that the FDA should regulate tobacco products. While he was not successful at the time, his efforts carried on as social stigma to tobacco smoke grew across the U.S., even in tobacco-growing states like North Carolina (from where this post has been written).

Passage of the Family Smoking Prevention and Tobacco Control Act of 2009, garnered both bipartisan support, the endorsement of the American Cancer Society and American Heart Association, as well as the endorsement of major tobacco companies. The Act continues to raise concerns as to the ethics of a regulatory safety agency should continue to allow sales of products know to still be the leading cause of death in the United States.

But the Center for Tobacco Products also allows for training and development of policies in this arena. In fact, interested mid-career investigators might care to apply for the third class of FDA-CTP-Institute of Medicine fellowships in tobacco regulatory science. You have one week to send your application in – the deadline is March 3, 2014. Application information is here.

Source: Forbes Business


2 weeks ago

Khazanah throws MAS RM6b lifeline

Aug 29 2014 5:01pm CDT | Source: Business Times Singapore

August 30, 2014 1:15 AMKHAZANAH Nasional will inject RM6 billion (SS$2.4 billion) over three years to resuscitate loss-making Malaysia Airlines (MAS) under a recovery plan that includes even an Act of Parliament. Other key moves are migrating its operations, assets and liabilities to a new company (NewCo) and slashing the workforce of ...
Source: Business Times Singapore   Full article at: Business Times Singapore


2 weeks ago

MAS posts loss of RM307m for Q2

Aug 28 2014 5:00pm CDT | Source: Business Times Singapore

August 29, 2014 1:13 AMMALAYSIA Airlines (MAS) registered a loss of RM307 million (S$122 million) for the second quarter to end-June, but warned of worse to come in the second half when the "full financial impact of the double tragedies of MH370 an ...
Source: Business Times Singapore   Full article at: Business Times Singapore


Don't miss ...


<a href="/latest_stories/all/all/30" rel="author">Forbes</a>
Forbes is among the most trusted resources for the world's business and investment leaders, providing them the uncompromising commentary, concise analysis, relevant tools and real-time reporting they need to succeed at work, profit from investing and have fun with the rewards of winning.


blog comments powered by Disqus

Latest stories

Travel bans complicated Ebola fight: WHO official
Nairobi, Sep 17 (IANS) Travel prohibitions to Ebola-hit West African countries have undermined the fight against the pandemic that has claimed 2,500 lives, a World Health Organisation (WHO) official said Wednesday.
Turkish president slams New York Times over IS charges
Ankara, Sep 17 (IANS) Turkish President Recep Tayyip Erdogan Wednesday slammed The New York Times for its report claiming that Turkey is one of the major sources of recruitment of the Islamic State (IS) terrorist group, saying that some foreign media outlets are trying to depict Turkey as a country that supports terrorism.
Oxford experts test vaccine against Ebola
London, Sep 17 (IANS/EFE) Experts at England's University of Oxford Wednesday launched clinical trials of a vaccine against the Ebola virus, which has killed more than half of the over 4,700 people affected in West Africa.
Medical irregularities found in Joan Rivers' death: Report
Los Angeles, Sep 17 (IANS/EFE) The personal doctor of Joan Rivers is being investigated for the death of the popular American comedian and television host who died a week after undergoing a minor throat operation.

Latest from the Network

Lady Gaga's career tears
Lady Gaga burst into tears today (17.09.14) because she cannot believe how successful she has been. The 28-year-old singer took to Twitter to pour her heart out and admit she is feeling ''overwhelmed'' by what she has...
Read more on Celebrity Balla
Arnold Schwarzenegger and Maria Shriver's divorce to be finalised
Arnold Schwarzenegger and Maria Shriver's divorce is set to be finalized in December. The couple - who tied the knot in 1986 - split three years ago and she filed for divorce in July 2011 following revelations he had...
Read more on Celebrity Balla
Kaley Cuoco throws good parties
Kaley Cuoco throws the ''best parties'' of the 'Big Bang Theory' cast. The sit-com stars - Kaley, Simon Helberg, Johnny Galecki, Jim Parsons, Kunal Nayyar, Mayim Bialik, and Melissa Rauch - are close friends off screen...
Read more on Celebrity Balla
Craig Ferguson took acid with Peter Capaldi instead of studying
Craig Ferguson was too busy ''taking acid'' with Peter Capaldi to study. The 'Late Late Show' presenter admits he is often asked for career tips on breaking into the TV industry, but claimed he ''doesn't know'' because...
Read more on Celebrity Balla
Stephanie Leonidas wants to be first female Doctor Who
Stephanie Leonidas wants to be the first female Doctor Who. The 30-year-old actress has revealed that if she was to take on a role in the BBC sci-fi series, it would have to be that of the titular Time Lord himself....
Read more on Celebrity Balla
Chanderpaul climbs to 3rd among Test batsmen
Dubai, Sep 17 (IANS) Riding on his two match-winning knocks against Bangladesh in the second Test, West Indies' veteran batsman Shivnarine Chanderpaul leapfrogged Angelo Mathews and David Warner to be positioned third...
Read more on Sport Balla
Apple Watch Could Cause More Road Accidents In the UK
The Apple Watch can be trendy and fashionable, but might be not very safe to use while driving, as an organization states that the device can cause major distractions, which might lead to serious road accidents.The...
Read more on Apple Balla
Ukraine government to verify 1 mn civil servants' loyalty
Kiev, Sep 17 (IANS) One million civil servants in Ukraine will be screened for their loyalty to the new government, Prime Minister Arseniy Yatseniuk has said. The parliament passed a new law Tuesday, allowing the...
Read more on Politics Balla
Five arrested in France on suspicion of recruiting jihadis
Paris, Sep 17 (IANS) French Interior Minister Bernard Cazeneuve Wednesday announced the arrest of five suspected recruiters for jihad in Syria as part of the government's plan against terrorism and recruitment drive...
Read more on Politics Balla
Hamas, Fatah await Egypt response for renewed dialogue
Ramallah, Sep 17 (IANS) Palestinian President Mahmoud Abbas's Fatah Party and the Hamas movement are awaiting Egypt's response on a proposed session of internal dialogue between the two Palestinian rivals in Cairo,...
Read more on Politics Balla